Elekta leads radiation therapy market in KLAS survey

Debra Beachy | | Health Imaging | Oncology Imaging

Elekta leads the highly competitive radiation therapy market in overall performance and cost rankings, according to Orem, Utah-based research firm KLAS.

KLAS surveyed 101 providers for the recently published report, “Radiation Therapy: The Fight Against Cancer is Heating Up.”

Elekta had the highest customer loyalty score, followed by market share leader Varian TrueBeam, Accuray CyberKnife and Accuray TomoTherapy.

Respondents were asked to compare cost, functionality and the downtime experienced using the different radiology therapy systems.

“Elekta earns the top spot (by a large margin) because of their continued technology improvement combined with a focus on partnering with providers,” read the report’s executive summary.

KLAS noted that Elekta’s provider-centric support for its Versa HD system aided its strong showing.

Newcomer RaySearch will be included in future surveys, according to KLAS.

Debra Beachy

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.